Viewing Study NCT04575961

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:03 PM
Ignite Modification Date: 2026-02-02 @ 4:48 PM
Study NCT ID: NCT04575961
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-05-23
First Post: 2020-09-07
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer
Sponsor: North Eastern German Society of Gynaecological Oncology
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
None Low Grade Serous Carcinoma View
None Primary Peritoneal Carcinoma View
None Fallopian Tube Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pembrolizumab View
None Chemotherapy View
None Platinum-Sensitive View